MannKind Corporation (MNKD) Stock: Is Now The Time To Get Involved?

MannKind Corporation (NASDAQ: MNKD) has been a very interesting stock to watch since 2014, when the United States Food and Drug Administration (FDA) approved the company’s inhaled insulin known as Afrezza. Considering that there were no needles to be used and the insulin was a fast-acting, after-meals option, investors believed that the treatment would fly off … Read more

Novavax (NVAX) Stock: Should You Buy The Dip?

Novavax, Inc. (NASDAQ: NVAX) isn’t having the best of starts to the trading session in the pre-market hours this morning. In fact, the stock is trading in the red. However, given recent news surrounding the company, many are wondering if this is a dip worth buying. Today, we’ll talk about the value proposition surrounding NVAX, what … Read more

Bioverativ (BIVV) Stock: Gaining After Sanofi (SNY) Announces Acquisition

Bioverativ Inc (NASDAQ: BIVV) is having an overwhelmingly strong day in the market today, and for good reason. Early this morning, it was announced that the company would be acquired by Sanofi SA (ADR) (NYSE: SNY). Of course, this led to excitement among investors, sending the stock screaming for the top. Today, we’ll talk about the announcement, … Read more

Flexion Therapeutics (FLXN) Stock: Gaining On Potential SNY Takeover!

Flexion Therapeutics Inc (NASDAQ: FLXN) | Sanofi SA (ADR) (NYSE: SNY) Flexion Therapeutics is having an overwhelmingly strong start to the trading session today. After FiercePharma made an announcement that the company is nearing a deal with Sanofi, the stock spiked in a big way, prompting our partners at Trade Ideas to alert us to … Read more

Sanofi SA (SNY), Novo Nordisk (NVO) And Eli Lilly (LLY) Stock…Being Sent To The Corn Field

Okay, so unless you are a Twilight Zone enthusiast , you may not catch much of what the title implies, but, trust me, the “corn field” isn’t the most comfortable place to live. And, as of just a short while ago, it appears that three of the biggest makers of diabetes treatments, Sanofi (SNY), Novo … Read more